- Report
- June 2022
- 120 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- June 2022
- 140 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- June 2022
- 88 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- January 2022
- 110 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- January 2022
- 117 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- January 2022
- 115 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- January 2022
- 120 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- July 2021
- 111 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- March 2021
- 120 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- June 2020
- 114 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- August 2025
- 215 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- February 2025
- 231 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- February 2025
- 233 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- January 2025
- 192 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- December 2024
- 139 Pages
United States
From €2242EUR$2,500USD£1,922GBP
- Report
- August 2024
- 170 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2024
- 141 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2024
- 164 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2024
- 185 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2024
- 174 Pages
Global
From €2242EUR$2,500USD£1,922GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more